EPHA3 and neoplasm: Based on this, Offenhäuser et al. [135] successfully demonstrated that the EphA3 antibody IIIA4 conjugated with the cytotoxic microtubule-targeting agent USAN was effective in inhibiting tumour growth in orthotopic xenograft models of glioma.